Dna heterogeneity determined by flow cytometry in prostatic adenocarcinoma-necessitating multiple site analysis.
- Published in:
- Prostate, 1995, v. 27, n. 6, p. 329, doi. 10.1002/pros.2990270606
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 1995 AND VI 27 AND IP 6
Results: 8
1
2
Effects of a new steroidal antiandrogen, TZP-4238 (17 α-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
- Published in:
- Prostate, 1995, v. 27, n. 6, p. 321, doi. 10.1002/pros.2990270605
- By:
- Publication type:
- Article
3
Abstracts.
- Published in:
- Prostate, 1995, v. 27, n. 6, p. 340, doi. 10.1002/pros.2990270608
- Publication type:
- Article
4
Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry.
- Published in:
- Prostate, 1995, v. 27, n. 6, p. 304, doi. 10.1002/pros.2990270603
- By:
- Publication type:
- Article
5
Adenocarcinoma of the prostate metastatic to the choroid of the eye.
- Published in:
- Prostate, 1995, v. 27, n. 6, p. 336, doi. 10.1002/pros.2990270607
- By:
- Publication type:
- Article
6
Current status of neoadjuvant therapy in localized prostate cancer.
- Published in:
- Prostate, 1995, v. 27, n. 6, p. 297, doi. 10.1002/pros.2990270602
- By:
- Publication type:
- Article
7
Retinoblastoma gene mutations in primary human prostate cancer.
- Published in:
- Prostate, 1995, v. 27, n. 6, p. 314, doi. 10.1002/pros.2990270604
- By:
- Publication type:
- Article
8
Masthead.
- Published in:
- Prostate, 1995, v. 27, n. 6, p. fmi, doi. 10.1002/pros.2990270601
- Publication type:
- Article